BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8931929)

  • 1. Key analogues of the tetrapeptide subunit of RA-VII and deoxybouvardin.
    Boger DL; Zhou J
    Bioorg Med Chem; 1996 Oct; 4(10):1597-603. PubMed ID: 8931929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key analogs of the tetrapeptide subunit of RA-VII and deoxybouvardin.
    Boger DL; Zhou J; Winter B; Kitos PA
    Bioorg Med Chem; 1995 Dec; 3(12):1579-93. PubMed ID: 8770383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of bouvardin, deoxybouvardin and RA-I-XIV pharmacophore analogs.
    Boger DL; Patane MA; Jin Q; Kitos PA
    Bioorg Med Chem; 1994 Feb; 2(2):85-100. PubMed ID: 7922127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of [Gly-1]RA-VII, [Gly-2]RA-VII, and [Gly-4]RA-VII. Glycine-containing analogues of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants.
    Hitotsuyanagi Y; Hasuda T; Aihara T; Ishikawa H; Yamaguchi K; Itokawa H; Takeya K
    J Org Chem; 2004 Mar; 69(5):1481-6. PubMed ID: 14987000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aza-cycloisodityrosine analogue of RA-VII, an antitumor bicyclic hexapeptide.
    Hitotsuyanagi Y; Miyazawa A; Hinosawa TA; Nakagawa Y; Hasuda T; Takeya K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6728-31. PubMed ID: 24268554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of [L-Ala-1]RA-VII, [D-Ala-2]RA-VII, and [D-Ala-4]RA-VII by epimerization of RA-VII, an antitumor bicyclic hexapeptide from Rubia plants, through oxazoles.
    Hitotsuyanagi Y; Sasaki S; Matsumoto Y; Yamaguchi K; Itokawa H; Takeya K
    J Am Chem Soc; 2003 Jun; 125(24):7284-90. PubMed ID: 12797802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Per-N-methylated analogues of an antitumor bicyclic hexapeptide RA-VII.
    Hitotsuyanagi Y; Lee JE; Kato S; Kim IH; Kohashi H; Fukaya H; Takeya K
    Bioorg Med Chem; 2011 Apr; 19(7):2458-63. PubMed ID: 21382716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of a bis(cycloisodityrosine) analogue of RA-VII, an antitumor bicyclic hexapeptide.
    Lee JE; Hitotsuyanagi Y; Nakagawa Y; Kato S; Fukaya H; Takeya K
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6458-61. PubMed ID: 18993061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of [Tyr-5-Ψ(CH2NMe)-Tyr-6]RA-VII, a reduced peptide bond analogue of RA-VII, an antitumor bicyclic hexapeptide.
    Hasuda T; Hitotsuyanagi Y; Shinada M; Takeya K
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2757-9. PubMed ID: 22460024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
    Loew G; Hashimoto G; Williamson L; Burt S; Anderson W
    Mol Pharmacol; 1982 Nov; 22(3):667-77. PubMed ID: 7155126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syntheses and Structure-Activity Relationship Studies of Antitumor Bicyclic Hexapeptide RA-VII Analogues].
    Hitotsuyanagi Y
    Yakugaku Zasshi; 2024; 144(5):553-565. PubMed ID: 38692932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution forms of an antitumor cyclic hexapeptide, RA-VII in dimethyl sulfoxide-d6 from nuclear magnetic resonance studies.
    Itokawa H; Morita H; Takeya K
    Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1050-2. PubMed ID: 1525934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures and conformations of metabolites of antitumor cyclic hexapeptides, RA-VII and RA-X.
    Itokawa H; Saitou K; Morita H; Takeya K; Yamada K
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):2984-9. PubMed ID: 1477912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RA-dimer B, a New Dimeric RA-series Cyclopeptide Incorporating Two Different Types of Cycloisodityrosine Units, from Rubia cordifolia L.
    Hitotsuyanagi Y; Tsuchiya T; Ohata M; Yoshida A; Fukaya H; Park HS; Takeya K; Kawahara N
    Chem Asian J; 2016 Dec; 11(23):3389-3397. PubMed ID: 27863076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational analysis of [n-demethyl-Tyr(OCH3)-3]RA-VII, conformationally restricted model approach.
    Itokawa H; Saitou K; Morita H; Takeya K
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2161-3. PubMed ID: 1797443
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation, structure determination, and synthesis of allo-RA-V and neo-RA-V, RA-series bicyclic peptides from Rubia cordifolia L.
    Hitotsuyanagi Y; Odagiri M; Kato S; Kusano J; Hasuda T; Fukaya H; Takeya K
    Chemistry; 2012 Mar; 18(10):2839-46. PubMed ID: 22298232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RA-XXV and RA-XXVI, Bicyclic Hexapeptides from Rubia cordifolia L.: Structure, Synthesis, and Conformation.
    Hitotsuyanagi Y; Hirai M; Odagiri M; Komine M; Hasuda T; Fukaya H; Takeya K
    Chem Asian J; 2019 Jan; 14(1):205-215. PubMed ID: 30393964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative Synthesis of the Cycloisodityrosine Subunit of Deoxybouvardin, RA-VII, and Related Agents: Reassignment of the Stereochemistry of Prior Intermediates.
    Boger DL; Zhou J
    J Org Chem; 1996 Jun; 61(12):3938-3939. PubMed ID: 11667262
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereochemistry rules: a single stereocenter changes the conformation of a cyclic tetrapeptide.
    Li F; Bravo-Rodriguez K; Fernandez-Oliva M; Ramirez-Anguita JM; Merz K; Winter M; Lehmann CW; Sander W; Sanchez-Garcia E
    J Phys Chem B; 2013 Sep; 117(37):10785-91. PubMed ID: 24011400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of the key macrolactamisation step in the synthesis of cyclic tetrapeptide pseudoxylallemycin A.
    Cameron AJ; Squire CJ; Gérenton A; Stubbing LA; Harris PWR; Brimble MA
    Org Biomol Chem; 2019 Apr; 17(16):3902-3913. PubMed ID: 30941386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.